Literature DB >> 10667297

Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis.

M R Gonçalves1, E R Barbosa, A A Zambon, P E Marchiori.   

Abstract

We report the case of a 49-year-old woman who has the rare combination of myasthenia gravis and cervical dystonia. She was treated with botulinum toxin type A with good response and no evidence of deterioration of the myasthenic symptoms. We therefore conclude that it is possible to use botulinum toxin in the presence of defective neuromuscular transmission.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10667297     DOI： 10.1590/s0004-282x1999000400024

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN： 0004-282X            Impact factor:   1.420


  4 in total

1.  The use of intra-detrusor onabotulinumtoxinA in patients with myasthenia gravis.

Authors:  Ian Wright; Andrea Civitarese; Richard Baverstock
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

Review 2.  Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.

Authors:  Maria Fiorella Contarino; Joost Van Den Dool; Yacov Balash; Kailash Bhatia; Nir Giladi; Johannes H Koelman; Annemette Lokkegaard; Maria J Marti; Miranda Postma; Maja Relja; Matej Skorvanek; Johannes D Speelman; Evelien Zoons; Joaquim J Ferreira; Marie Vidailhet; Alberto Albanese; Marina A J Tijssen
Journal:  Front Neurol       Date:  2017-02-24       Impact factor: 4.003

3.  Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.

Authors:  Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-10-16       Impact factor: 3.575

4.  Cosmetic Injection of Botulinum Toxin Unmasking Subclinical Myasthenia Gravis: A Case Report and Literature Review.

Authors:  Grégory Timmermans; Frédérique Depierreux; François Wang; Isabelle Hansen; Pierre Maquet
Journal:  Case Rep Neurol       Date:  2019-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.